2022
DOI: 10.1016/j.tice.2022.101753
|View full text |Cite
|
Sign up to set email alerts
|

Aspirin effect on bone remodeling and skeletal regeneration: Review article

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 113 publications
1
8
0
Order By: Relevance
“…91 Previous studies reported that local delivery of aspirin via a scaffold could upregulate osteogenic proteins and the mineralization of stem cells under inflammatory conditions. 92,93 Accordingly, as expected, after implantation of ASA@tHALLG nanocomposites into defects, the released aspirin from the GCP assembly enhanced the osteogenic potential of hPDLSCs at bone-ligament interfaces, eventually leading to an accelerated remodeling of periodontal bone tissue. Moreover, it is noted that due to the anti-inflammatory activity of aspirin, the host inflammatory response was markedly inhibited during the healing process of the defects treated with ASA@tHALLG nanocomposites, as indicated by the significantly reduced positive staining areas of TNF-α and IL-1β (Figure S3) in the defect regions.…”
Section: Dovepresssupporting
confidence: 61%
See 1 more Smart Citation
“…91 Previous studies reported that local delivery of aspirin via a scaffold could upregulate osteogenic proteins and the mineralization of stem cells under inflammatory conditions. 92,93 Accordingly, as expected, after implantation of ASA@tHALLG nanocomposites into defects, the released aspirin from the GCP assembly enhanced the osteogenic potential of hPDLSCs at bone-ligament interfaces, eventually leading to an accelerated remodeling of periodontal bone tissue. Moreover, it is noted that due to the anti-inflammatory activity of aspirin, the host inflammatory response was markedly inhibited during the healing process of the defects treated with ASA@tHALLG nanocomposites, as indicated by the significantly reduced positive staining areas of TNF-α and IL-1β (Figure S3) in the defect regions.…”
Section: Dovepresssupporting
confidence: 61%
“… 67 , 101 , 102 Cun-Yu Wang et al previously proved that activation of NF-κB can inhibit osteogenic differentiation of stem cells by promoting β-catenin degradation. 98 Based on above inflammation mediated regulatory mechanism, aspirin released from ASA@tHALLG nanocomposites may interfere NF-κB signaling pathway through inhibition of inflammatory response, 57 , 92 in turn enhancing Wnt-dependent osteogenic commitment of PDLSCs, the critical cells responsible for regeneration of periodontal tissue, in inflammatory microenvironment. 67 , 103 Therefore, in agreement with the in vitro experiments, the results obtained from the in vivo studies demonstrated that the ASA@tHALLG nanocomposites possessed an excellent capacity to facilitate the reconstruction of periodontal bone tissue, with great potential for applications in periodontal and bone tissue engineering.…”
Section: Resultsmentioning
confidence: 99%
“…Invaluable qualities such as interconnected porous morphology and architecture similar to extracellular matrix (ECM), irreplaceable water retention capacity, drugs and growth factors delivery effect, and biodegradability enable hydrogel to adapt to specific physical and soft tissue regeneration environment ( Han et al, 2021 ; Sreekumaran et al, 2021 ; Sun et al, 2022 ). Furthermore, some attention has been fortunately drawn to the roles of the non-steroidal anti-inflammatory drug (NSAIDs) of aspirin, since it is used to alleviate the inflammation and activate osteoblasts in the surgical site within the concentration range of 50–300 μg/mL ( Fattahi et al, 2022 ). Studies have confirmed that an appropriate dose of aspirin can improve trabecular bone structure, bone mineral density, and bone mechanical strength ( Tao et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…It can also inhibit the expression of nuclear-factor-κB-mediated inflammatory cytokines (e.g., TNF-α), which has important anti-inflammatory effects [ 36 , 37 , 38 , 39 ]. Aspirin is widely used in bone regeneration [ 40 ]. Studies have confirmed that aspirin can promote the osteogenic differentiation of mesenchymal stem cells and inhibits the expression of inflammatory factors to activate osteoblasts and inhibit osteoclasts [ 41 ].…”
Section: Discussionmentioning
confidence: 99%